Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.83 is 41% above its 5-year average of 1.30, near the high end of its 5-year range (0.76–1.83).
As of the fiscal period ended Tuesday, June 30, 2026. 5.96% above its 12-month average of 1.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.83.
CURRENT RATIO
1.83
CURRENT RATIO AVG TTM
1.72
CURRENT RATIO AVG 3Y
1.46
CURRENT RATIO AVG 5Y
1.30
CURRENT RATIO AVG 10Y
1.27
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.96%
CURRENT VS 3Y AVG
+24.75%
CURRENT VS 5Y AVG
+40.61%
CURRENT VS 10Y AVG
+44.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
-49.19%
vs the sector median at left
Market Cap
$101.24M
Current Ratio
26.75
TTM Avg
10.50
3Y Avg
7.03
5Y Avg
10.82
Market Cap
$104.68M
Current Ratio
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$104.79M
Current Ratio
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.36
Market Cap
$105.20M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
Market Cap
$106.68M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$107.44M
Current Ratio
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $102.65M | 1.83 | 1.72 | 1.46 | 1.30 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $101.24M | 26.75 | 10.50 | 7.03 | 10.82 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | 8.54 | 8.31 | 10.99 | 13.36 |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | 1.86 | 1.97 | 2.28 | 2.24 |
| PolyPid Ltd. (PYPD)vs › | $98.85M | 1.35 | 1.64 | 1.44 | 4.41 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.68M | 0.96 | 1.08 | 1.26 | 1.56 |
| Immunic, Inc. (IMUX)vs › | $107.34M | 5.05 | 1.26 | 3.56 | 6.57 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | 7.28 | 6.67 | 7.13 | 10.02 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.25M | 8.13 | 8.55 | 9.73 | 13.44 |
Current Ratio
1.83
Quick Ratio
1.83
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.83 |
| 2026-03-31 | 1.61 |
| 2025-12-31 | 1.59 |
| 2025-09-30 | 1.80 |
| 2025-06-30 | 1.80 |
| 2025-03-31 | 1.59 |
| 2024-12-31 | 1.52 |
| 2024-09-30 | 1.44 |
| 2024-06-30 | 1.28 |
| 2024-03-31 | 1.34 |
| 2023-12-31 | 1.32 |
| 2023-09-30 | 1.03 |
| 2023-06-30 | 0.90 |
| 2023-03-31 | 0.94 |
| 2022-12-31 | 0.76 |
| 2022-09-30 | 0.87 |
| 2022-06-30 | 0.87 |
| 2022-03-31 | 1.25 |
| 2021-12-31 | 1.25 |
| 2021-09-30 | 1.19 |
| 2021-06-30 | 1.10 |
| 2021-03-31 | 1.31 |
| 2020-12-31 | 1.37 |
| 2020-09-30 | 1.38 |
| 2020-06-30 | 1.27 |
| 2020-03-31 | 1.15 |
| 2019-12-31 | 0.98 |
| 2019-09-30 | 0.84 |
| 2019-06-30 | 1.04 |
| 2019-03-31 | 1.00 |
| 2018-12-31 | 1.34 |
| 2018-09-30 | 1.36 |
| 2018-06-30 | 1.30 |
| 2018-03-31 | 1.17 |
| 2017-12-31 | 1.34 |
| 2017-09-30 | 1.32 |
| 2017-06-30 | 1.22 |
| 2017-03-31 | 1.16 |
| 2016-12-31 | 0.97 |
| 2016-09-30 | 1.39 |
| 2016-06-30 | 1.77 |
| 2016-03-31 | 2.21 |
| 2015-12-31 | 2.54 |
| 2015-09-30 | 1.97 |
| 2015-06-30 | 2.73 |
| 2015-03-31 | 4.09 |
| 2014-12-31 | 4.88 |
| 2014-09-30 | 1.38 |
| 2014-06-30 | 1.38 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 1.58 |
| 2013-09-30 | 0.00 |
